Sonoma Pharmaceuticals (SNOA) EBIT (2010 - 2025)
Sonoma Pharmaceuticals (SNOA) recorded quarterly EBIT of -$678000.0 in Q4 2025, down 101.19% quarter-over-quarter from -$337000.0 in Q3 2025, and up 34.24% on a YoY basis from -$505070.8 in Q4 2024.
Sonoma Pharmaceuticals (SNOA) EBIT (2010 - 2025) Analysis & Trends
Sonoma Pharmaceuticals' EBIT history runs 16 years deep, the most recent figure standing at -$678000.0 for Q4 2025.
- In Q4 2025, EBIT rose 34.24% year-over-year to -$678000.0; the TTM figure through Dec 2025 stood at -$2.8 million (up 38.02% YoY), while the FY2025 annual figure was -$3.7 million, up 21.08% from the prior year.
- EBIT was -$678000.0 for Q4 2025 at Sonoma Pharmaceuticals, down from -$337000.0 in the prior quarter.
- In the past five years, EBIT ranged from a high of -$337000.0 in Q3 2025 to a low of -$3.1 million in Q1 2022.
- Historically, EBIT has averaged -$1.2 million across 5 years, with a median of -$997500.0 in 2021.
- The sharpest annual moves came in 2021 and 2023: EBIT plunged 670.41% in 2021, then jumped 62.52% in 2023.
- A 5-year view of EBIT shows it stood at -$958000.0 in 2021, then slumped by 91.44% to -$1.8 million in 2022, then jumped by 53.98% to -$844000.0 in 2023, then decreased by 22.16% to -$1.0 million in 2024, then jumped by 34.24% to -$678000.0 in 2025.
- The last three EBIT figures came in at -$678000.0 (Q4 2025), -$337000.0 (Q3 2025), and -$1.1 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 652.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 833.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 325.80 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 14.03 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 193.40 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 307.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -48.28 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 81.33 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -78.32 Mn |
| 10 | Sonoma Pharmaceuticals | 1.90 Mn | -659,569.98 | 1.65 Mn | -678,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -678,000.00 |
| Sep 30, 2025 | -337,000.00 |
| Jun 30, 2025 | -1.10 Mn |
| Mar 31, 2025 | -656,000.00 |
| Dec 31, 2024 | -1.03 Mn |
| Sep 30, 2024 | -850,000.00 |
| Jun 30, 2024 | -1.17 Mn |
| Mar 31, 2024 | -1.41 Mn |
| Dec 31, 2023 | -844,000.00 |
| Sep 30, 2023 | -1.21 Mn |
| Jun 30, 2023 | -1.24 Mn |
| Mar 31, 2023 | -1.15 Mn |
| Dec 31, 2022 | -1.83 Mn |
| Sep 30, 2022 | -731,000.00 |
| Jun 30, 2022 | -855,000.00 |
| Mar 31, 2022 | -3.06 Mn |
| Dec 31, 2021 | -958,000.00 |
| Sep 30, 2021 | -964,000.00 |
| Jun 30, 2021 | -904,000.00 |
| Mar 31, 2021 | -2.81 Mn |